scispace - formally typeset
P

Pan Zheng

Researcher at University of Maryland, Baltimore

Publications -  241
Citations -  13998

Pan Zheng is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Antigen & Cytotoxic T cell. The author has an hindex of 55, co-authored 209 publications receiving 12059 citations. Previous affiliations of Pan Zheng include Peking Union Medical College & Westat.

Papers
More filters
Journal ArticleDOI

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

TL;DR: It is demonstrated that in mammalian cells, the transcription coactivator YAP (Yes-associated protein), is inhibited by cell density via the Hippo pathway, and YAP overexpression regulates gene expression in a manner opposite to cell density, and is able to overcome cell contact inhibition.
Journal ArticleDOI

CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses

TL;DR: The results reveal that the CD24–Siglec G pathway protects the host against a lethal response to pathological cell death and discriminates danger- versus pathogen-associated molecular patterns.
Journal ArticleDOI

TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species

TL;DR: It is demonstrated that Tsc1 deletion in the HSCs drives them from quiescence into rapid cycling, with increased mitochondrial biogenesis and elevated levels of reactive oxygen species (ROS), which may explain the well-documented association between quiescent and the “stemness” of H SCs.
Journal ArticleDOI

mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells

TL;DR: In old mice, rapamycin increased life span, restored the self-renewal and hematopoiesis of HSCs, and enabled effective vaccination against a lethal challenge with influenza virus.
Journal ArticleDOI

Targeting HIF1α eliminates cancer stem cells in hematological malignancies.

TL;DR: It is found that, under normoxia, HIF1α signaling was selectively activated in the stem cells of mouse lymphoma and human acute myeloid leukemia (AML) and this work demonstrates an essential function of Hif1α-Notch interaction in maintaining CSCs and provides an effective approach to target C SCs for therapy of hematological malignancies.